APA

Claveau D., Chen S. L., O'Keefe S., Zaller D. M., Styhler A., Liu S., Huang Z., Nicholson D. W. & Mancini J. A. (20050328). Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitor. : The Journal of pharmacology and experimental therapeutics.

Chicago

Claveau D, Chen S L, O'Keefe S, Zaller D M, Styhler A, Liu S, Huang Z, Nicholson D W and Mancini J A. 20050328. Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitor. : The Journal of pharmacology and experimental therapeutics.

Harvard

Claveau D., Chen S. L., O'Keefe S., Zaller D. M., Styhler A., Liu S., Huang Z., Nicholson D. W. and Mancini J. A. (20050328). Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitor. : The Journal of pharmacology and experimental therapeutics.

MLA

Claveau D, Chen S L, O'Keefe S, Zaller D M, Styhler A, Liu S, Huang Z, Nicholson D W and Mancini J A. Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitor. : The Journal of pharmacology and experimental therapeutics. 20050328.